Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
ICD-10 C77.3 is a billable code used to indicate a diagnosis of secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes.
C77.3 refers to secondary malignant neoplasms that have metastasized to the axillary and upper limb lymph nodes. This condition typically arises from a primary cancer located elsewhere in the body, such as breast, lung, or melanoma. The axilla and upper limb lymph nodes serve as critical sites for lymphatic drainage, making them common locations for metastatic spread. Patients may present with swollen lymph nodes, pain, or other systemic symptoms related to the underlying malignancy. Accurate coding is essential for appropriate treatment planning, staging, and palliative care considerations. In cases where the primary tumor is unknown, thorough diagnostic workup is necessary to identify potential sources of metastasis. Staging of the disease is crucial for determining prognosis and treatment options, and palliative care may be indicated to manage symptoms and improve quality of life for patients with advanced disease.
Detailed history of the primary malignancy, staging information, and treatment plans.
Patients with known primary cancers presenting with axillary lymphadenopathy.
Ensure accurate documentation of metastasis and staging to support treatment decisions.
Comprehensive symptom management plans and goals of care discussions.
Patients with advanced cancer requiring symptom relief and quality of life improvements.
Documentation should reflect the focus on palliative care interventions and patient preferences.
Used when lymph nodes are biopsied to confirm metastatic disease.
Document the indication for biopsy and results.
Oncology specialists should ensure clear documentation of the biopsy findings.
Accurate coding of C77.3 is crucial for appropriate treatment planning, staging, and reimbursement. It ensures that patients receive the necessary care for metastatic disease and helps in tracking cancer epidemiology.
